Add Yahoo as a preferred source to see more of our stories on Google. Last fall, U.S. health officials authorized new COVID-19 booster shots designed to target the original strain of the coronavirus ...

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...

Last week, the CDC published initial data with promising implications for people who get the updated Covid-19 boosters. Scientists designed the updated, bivalent mRNA boosters to combat the omicron ...

For months, many people have been wondering, “When can I get a second bivalent COVID booster?” — especially if they got their first bivalent booster seven months ago, in September 2022, back when ...

The U.S. Food and Drug Administration amended the terms of its emergency use authorizations for the Pfizer and Moderna bivalent vaccines on Tuesday, allowing people ages 65 and older and certain ...

Three years into the pandemic, COVID-19 vaccines are an increasingly hard sell – especially in Georgia. According to the Centers for Disease Control and Prevention. Only about 10% of residents in the ...

Neil Mabbott does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Many seniors can now get another COVID-19 vaccine booster, after the Centers for Disease Control and Prevention greenlighted a broad swath of changes on Wednesday that were first authorized by the ...

The Omicron variant has morphed into more than half a dozen different strains—the latest of which include BQ.1.1 and XBB.1, and XBB.1.5. Combined, these variants and their close relatives now account ...

The Food and Drug Administration (FDA) on Thursday announced it has expanded the emergency use authorization for the bivalent COVID-19 booster to include children between the ages of 6 months and 5 ...

The current generation of monoclonal antibodies is ineffective against the predominant variants of SARS-CoV-2 in circulation. Recent studies by Callaway et al. open the possibility that a new type of ...